Jyong Biotech MENS
NASDAQ MENS
$1.74 -0.15 (-7.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Total Liabilities (2024 - 2025)

Updated

Jyong Biotech's Total Liabilities came in at $45.68 million for the quarter ended Dec 31, 2025, up 6.5% from $42.89 million a year earlier.

Analysis

Jyong Biotech (MENS) Total Liabilities (2024 - 2025) Analysis & Trends

  • Going back by year, Total Liabilities was $42.89 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 108.40 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 115.90 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 141.05 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 87.82 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 65.46 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 83.95 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 37.53 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 115.64 Bn
10 Jyong Biotech 121.38 Mn 121.38 Mn - 45.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 45.68 Mn
Jun 30, 2025 60.14 Mn
Dec 31, 2024 42.89 Mn
API Access

Jyong Biotech Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=MENS&period=max&api_key=YOUR_API_KEY